Ligand Pharmaceuticals Inc

Ligand Pharmaceuticals Inc., based in San Diego, CA, is a specialist in healthcare investing, focusing on the clinical development and commercialization of high-value medicines. The company boasts one of the largest and most diverse portfolios of biopharmaceutical royalties, featuring over 90 partnered commercial and development stage programs across various disease areas, including cancer and rare conditions.

In addition to its royalty portfolio, Ligand maintains and licenses its proprietary technology platforms, Captisol and NITRICIL, to a wide network of biopharmaceutical partners, including major pharmaceutical manufacturers globally. The company's economic rights extend to more than 30 commercial programs marketed in over 70 countries, illustrating its significant impact in advancing tomorrow's medicines through technology and financial solutions.

Generated from the website